A recent study at the University of Oxford, Britain, revealed the effectiveness of the treatment of gout in the face of the Corona virus, after it proved its ability to reduce the risk rates resulting from complications of the Coronavirus by 30%, according to a report published in the British Daily Mail.
The British study said that the treatment of gout patients contributes to the treatment of late cases after infection with the virus by 25%, as a study was conducted on 4000 people that took a daily dose of the anti-inflammatory colchicine treatment, and showed its ability to reduce the risks of entering Corona virus patients who suffer from health conditions Essential to the hospital.
The researchers confirmed the study the effectiveness of the gout drug, which encourages the expansion of its use to counter the risks resulting from the virus, especially that its cost is very low and it was tried on a large scale in the largest clinical trial in the world to treat Corona patients in hospital, and although the experiment discovered that the steroid Dexamethasone It can reduce the risk of dying among the most dangerous diseases, but until now there are no drugs that can decisively treat complications of the virus.
A Canadian study demonstrated the effectiveness of the anti-inflammatory drug colchicine, by reducing the risk of death by 44%, and the risk of patients requiring mechanical ventilation by half, especially patients over the age of forty and had at least one underlying health condition, including obesity, diabetes or high blood pressure. .
– .
